These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 20958325)

  • 1. Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms.
    Tartaglia M; Gelb BD
    Ann N Y Acad Sci; 2010 Dec; 1214():99-121. PubMed ID: 20958325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mosaic RASopathies.
    Hafner C; Groesser L
    Cell Cycle; 2013 Jan; 12(1):43-50. PubMed ID: 23255105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
    Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
    Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular aspects of RAS related disorders.
    Denayer E; de Ravel T; Legius E
    J Med Genet; 2008 Nov; 45(11):695-703. PubMed ID: 18550698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RASopathies.
    Rauen KA
    Annu Rev Genomics Hum Genet; 2013; 14():355-69. PubMed ID: 23875798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.
    Tidyman WE; Rauen KA
    Curr Opin Genet Dev; 2009 Jun; 19(3):230-6. PubMed ID: 19467855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade.
    Cesarini L; Alfieri P; Pantaleoni F; Vasta I; Cerutti M; Petrangeli V; Mariotti P; Leoni C; Ricci D; Vicari S; Selicorni A; Tartaglia M; Mercuri E; Zampino G
    Am J Med Genet A; 2009 Feb; 149A(2):140-6. PubMed ID: 19133693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
    Zhang J; Lodish HF
    Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.
    Steelman LS; Franklin RA; Abrams SL; Chappell W; Kempf CR; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo P; Ruvolo V; Evangelisti C; Martelli AM; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1080-94. PubMed ID: 21494257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
    Tidyman WE; Rauen KA
    Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis.
    Flex E; Jaiswal M; Pantaleoni F; Martinelli S; Strullu M; Fansa EK; Caye A; De Luca A; Lepri F; Dvorsky R; Pannone L; Paolacci S; Zhang SC; Fodale V; Bocchinfuso G; Rossi C; Burkitt-Wright EM; Farrotti A; Stellacci E; Cecchetti S; Ferese R; Bottero L; Castro S; Fenneteau O; Brethon B; Sanchez M; Roberts AE; Yntema HG; Van Der Burgt I; Cianci P; Bondeson ML; Cristina Digilio M; Zampino G; Kerr B; Aoki Y; Loh ML; Palleschi A; Di Schiavi E; Carè A; Selicorni A; Dallapiccola B; Cirstea IC; Stella L; Zenker M; Gelb BD; Cavé H; Ahmadian MR; Tartaglia M
    Hum Mol Genet; 2014 Aug; 23(16):4315-27. PubMed ID: 24705357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum.
    Motta M; Pannone L; Pantaleoni F; Bocchinfuso G; Radio FC; Cecchetti S; Ciolfi A; Di Rocco M; Elting MW; Brilstra EH; Boni S; Mazzanti L; Tamburrino F; Walsh L; Payne K; Fernández-Jaén A; Ganapathi M; Chung WK; Grange DK; Dave-Wala A; Reshmi SC; Bartholomew DW; Mouhlas D; Carpentieri G; Bruselles A; Pizzi S; Bellacchio E; Piceci-Sparascio F; Lißewski C; Brinkmann J; Waclaw RR; Waisfisz Q; van Gassen K; Wentzensen IM; Morrow MM; Álvarez S; Martínez-García M; De Luca A; Memo L; Zampino G; Rossi C; Seri M; Gelb BD; Zenker M; Dallapiccola B; Stella L; Prada CE; Martinelli S; Flex E; Tartaglia M
    Am J Hum Genet; 2020 Sep; 107(3):499-513. PubMed ID: 32721402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
    Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS diseases in children.
    Niemeyer CM
    Haematologica; 2014 Nov; 99(11):1653-62. PubMed ID: 25420281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Validation of Cell Proliferation via Ras-Independent Activation of the Raf/Mek/Erk Pathway.
    Lechuga CG; Simón-Carrasco L; Jacob HK; Drosten M
    Methods Mol Biol; 2017; 1487():269-276. PubMed ID: 27924574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RTK/Ras/MAPK signaling.
    Sundaram MV
    WormBook; 2006 Feb; ():1-19. PubMed ID: 18050474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
    Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
    Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction.
    Zhong J
    Biol Chem; 2016 Mar; 397(3):215-22. PubMed ID: 26760308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence.
    Wang W; Chen JX; Liao R; Deng Q; Zhou JJ; Huang S; Sun P
    Mol Cell Biol; 2002 May; 22(10):3389-403. PubMed ID: 11971971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.